CSF2 and cancer: Indeed in contrast with previous observations, it has been reported that high doses of GM-CSF can sustain cancer-related immunosuppression by increasing the number of immature myeloid cells (MDSCs) that actively suppresses anti-tumor T cell immunity (34).